| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 23, 2026 | ±2.8% | -0.4% | over-priced |
| October 30, 2025 | ±2.9% | +2.6% | over-priced |
| August 7, 2025 | ±2.4% | -1.8% | over-priced |
| April 24, 2025 | ±3.1% | -0.7% | over-priced |
| October 31, 2024 | ±2.4% | -0.3% | over-priced |
| July 25, 2024 | ±1.5% | +1.0% | over-priced |
| April 25, 2024 | ±1.8% | -0.6% | over-priced |
| October 26, 2023 | ±2.1% | -0.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | — | $1.0B | $150M |
| Q3 FY2025 | — | $1.1B | $183M |
| Q2 FY2025 | — | $1.1B | $175M |
| Q1 FY2025 | — | $989M | $138M |
Erie Indemnity Co (ERIE) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 1.0% on average — the market has systematically over-priced ERIE's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 9.5%. QuantLogix's live 5-factor engine currently reads ERIE as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →